5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To investigate the efficacy and toxicity of 68Ga-PSMA-HBED-CC (68Ga-PSMA) PET-CT-guided RT in the treatment of oligometastatic prostate cancer retrospectively.

          Related collections

          Author and article information

          Journal
          Clin Transl Oncol
          Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
          Springer Nature America, Inc
          1699-3055
          1699-048X
          Apr 2018
          : 20
          : 4
          Affiliations
          [1 ] Department of Radiation Oncology, Faculty of Medicine, Karadeniz Technical University, Trabzon, 61080, Turkey. ocguler@gmail.com.
          [2 ] Department of Radiotherapy, UZ Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, B-1090 , Brussels, Belgium.
          [3 ] Department of Radiation Oncology, Faculty of Medicine, Baskent University, Adana, Turkey.
          [4 ] Department of Nuclear Medicine, UZ Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, B-1090 , Brussels, Belgium.
          Article
          10.1007/s12094-017-1736-9
          10.1007/s12094-017-1736-9
          28795303
          ddf83102-1bd6-4f2e-a9c0-f632281617c4
          History

          Prostate-specific membrane antigen,Image-guided radiotherapy,Oligometastatic prostate cancer,Radiotherapy

          Comments

          Comment on this article